In addition, new evidence suggests that microglial TREM2 activation reduces microglia-mediated neuroinflammation and ameliorates cognitive impairment via the PI3K/Akt signaling pathway (43, 44), indicating the TREM2/PI3K/Akt pathway may be a potential neuroprotective target. This evidence concerns the gene AKT1 and Cognitive impairment.